Oncology Reports

Male breast cancer: Risk factors, diagnosis, and management (Review)
pp. 1115-1120(6)
Authors: Johansen Taber, Katherine A.; Morisy, Lee R.; Osbahr, Albert J.; Dickinson, Barry D.

Chemotherapy for breast cancer (Review)
pp. 1121-1131(11)
Authors: Hassan, M. S.U.; Ansari, J.; Spooner, D.; Hussain, S. A.

Characterization of an alternative transcript of the human CREB3L2 gene
pp. 1133-1139(7)
Authors: Panagopoulos, Ioannis; Monsef, Nastaran; Collin, Anna; Mertens, Fredrik

Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS
pp. 1141-1146(6)
Authors: Furugaki, Koh; Iwai, Toshiki; Shirane, Masatoshi; Kondoh, Kumiko; Moriya, Yoichiro; Mori, Kazushige

Analogy between sphere forming ability and stemness of human hepatoma cells
pp. 1147-1151(5)
Authors: Uchida; Tanaka; Aihara; Adikrisna; Yoshitake; Matsumura; Mitsunori; Murakata; Noguchi; Irie; Kudo; Nakamura; Lai; Arii

Scutellarin inhibits cell migration by regulating production of αvβ6 integrin and E-cadherin in human tongue cancer cells
pp. 1153-1160(8)
Authors: Li; Huang; Gao; Lv; Zhang; Cui; Zheng

Non-surgical care for locally advanced breast cancer: Radiologically assessed therapeutic outcome of a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II) with systemic chemotherapy
pp. 1161-1168(8)
Authors: Miyatake, Kana; Kubota, Kei; Ogawa, Yasuhiro; Hamada, Norihiko; Murata, Yoriko; Nishioka, Akihito

Induction of apoptosis by HAC-Y6, a novel microtubule inhibitor, through activation of the death receptor 4 signaling pathway in human hepatocellular carcinoma cells
pp. 1169-1178(10)
Authors: Tsai, Jui-Ying; Hung, Chao-Ming; Bai, Shih-Ting; Huang, Chi-Hung; Chen, Wei-Chih; Chung, Jinh-Gung; Kuo, Sheng-Chu; Way, Tzong-Der; Huang, Li-Jiau

Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo
pp. 1179-1184(6)
Authors: Wu; Song; Zhou; Xing; Pei; Zheng

Discrepancy of biologic behavior influenced by bone marrow derived cells in lung cancer
pp. 1185-1192(8)
Authors: Zhang; Niu; Liao; Liu; Sha; Zhao; Yu; Tan; Xiang; Fang; Lv; Li; Lu; Chen

Regulation of apoptosis by p53-inducible transmembrane protein containing sushi domain
pp. 1193-1200(8)
Authors: Cui; Kamino; Nakamura; Kitamura; Miyamoto; Shinogi; Goda; Arakara; Futamura

Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients
pp. 1201-1212(12)
Authors: Takahashi, Shusaku; Kamiyama, Toshiya; Tomaru, Utano; Ishizu, Akihiro; Shida, Toshiyuki; Osaka, Mineji; Sato, Yutaka; Saji, Yutaka; Ozaki, Michitaka; Todo, Satoru

Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck
pp. 1213-1216(4)
Authors: Schultz; Bran; Anders; Sadick; Faber; Hörmann; Sauter

Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186* signaling pathway
pp. 1217-1223(7)
Authors: Zhang, Jian; Du, Yongping; Wu, Changgui; Ren, Xinling; Ti, Xinyu; Shi, Jieran; Zhao, Feng; Yin, Hong

Differential expression of hedgehog signaling components and Snail/E-cadherin in human brain tumors
pp. 1225-1232(8)
Authors: Chou, Chia-Hua; Lieu, Ann-Shung; Wu, Chia-Hung; Chang, Li-Kwan; Loh, Joon-Khim; Lin, Run-Chin; Chen, Wei-Jay; Liao, Huei-De; Fu, Wen-Shane; Chang, Chung-Shing; Lin, Ching-Chih; Hsu, Ching-Mei; Chio, Chung-Ching; Howng, Shen-Long; Hong, Yi-Ren

Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: Insights from PyMT transgenic mouse model
pp. 1233-1239(7)
Authors: McCune; Mehta; Thorat; Badve; Nakshatri

MMP13 is a potential prognostic marker for colorectal cancer
pp. 1241-1247(7)
Authors: Huang, Ming-Yii; Chang, Hui-Jen; Chung, Fu-Yen; Yang, Ming-Je; Yang, Yu-Hsiang; Wang, Jaw-Yuan; Lin, Shiu-Ru

Induction of a less aggressive phenotype in human colon carcinoma HCT116 cells by chronic exposure to HDAC inhibitor SAHA
pp. 1249-1255(7)
Authors: Bressan, Alessandro; Bigioni, Mario; Bellarosa, Daniela; Nardelli, Federica; Irrissuto, Clelia; Maggi, Carlo Alberto; Binaschi, Monica

The distribution and expression profiles of human Aspartyl/Asparaginyl beta-hydroxylase in tumor cell lines and human tissues
pp. 1257-1264(8)
Authors: Yang, Hui; Song, Kai; Xue, Tian; Xue, Xiao-Ping; Huyan, Ting; Wang, Wei; Wang, Hua

Overexpression of BDNF and TrkB in human bladder cancer specimens
pp. 1265-1270(6)
Authors: Lai, Pei Chun; Chiu, Ted H.; Huang, Yen Ta

Diagnostic value of serum haptoglobin protein as hepatocellular carcinoma candidate marker complementary to α fetoprotein
pp. 1271-1276(6)
Authors: Shu; Kang; Guo; Li; Li; Sun; Gan; Liu; Qin

A cluster of inflammatory breast cancer (IBC) in an office setting: Additional evidence of the importance of environmental factors in IBC etiology
pp. 1277-1284(8)
Authors: Duke, Tina J.; Jahed, Nasreen C.; Veneroso, Carmela C.; Da Roza, Ricardo; Johnson, Owen; Hoffman, Daniel; Barsky, Sanford H.; Levine, Paul H.

Oncolytic adenovirus mediated Survivin RNA interference and 5-fluorouracil synergistically suppress the lymphatic metastasis of colorectal cancer
pp. 1285-1290(6)
Authors: Shen, Wei; Tu, Jing-Kai; Wang, Xue-Hu; Fu, Zhong-Xue

erbB2 gene silencing and its effect on PTEN in SACC-83 salivary adenoid cystic carcinoma cells
pp. 1291-1296(6)
Authors: Liu, Xiaohua; Zhang, Yincheng; Ren, Wenhao; Rao, Guozhou

Replication-dependent γ-H2AX formation is involved in docetaxel-induced apoptosis in NSCLC A549 cells
pp. 1297-1305(9)
Authors: Zhang; Zhang; Qu; Jiang; Cao; Li; Fan; Mei

Gimeracil, a component of S-1, may enhance the antitumor activity of X-ray irradiation in human cancer xenograft models in vivo
pp. 1307-1313(7)
Authors: Fukushima; Sakamoto; Sakata; Nakagawa; Saito; Sakata

Thalidomide enhances cyclophosphamide and dexamethasone-mediated cytotoxicity towards cultured chronic lymphocytic leukaemia cells
pp. 1315-1321(7)
Authors: Pointon; Eagle; Bailey; Evans; Allsup; Greenman

Vaccination of full-length HPV16 E6 or E7 protein inhibits the growth of HPV16 associated tumors
pp. 1323-1329(7)
Authors: Li, Yan-Li; Qiu, Xu-Hua; Shen, Chen; Liu, Jian-Ning; Zhang, Jing

Estrogen receptor β and epidermal growth factor receptor as early-stage prognostic biomarkers of non-small cell lung cancer
pp. 1331-1338(8)
Authors: Mauro; Dalurzo; Carlini; Smith; Nuñez; Simian; Lastiri; Vasallo; Bal de Kier Joffé; Pallotta; Puricelli

Knockdown of the c-Jun-N-terminal kinase expression by siRNA inhibits MCF-7 breast carcinoma cell line growth
pp. 1339-1345(7)
Authors: Parra, Eduardo; Ferreira, Jorge

Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population
pp. 1347-1353(7)
Authors: Hlavata; Vrana; Smerhovsky; Pardini; Naccarati; Vodicka; Novotny; Mohelnikova-Duchonova; Soucek

Analysis of stemness gene expression and CD133 abnormal methylation in neuroblastoma cell lines
pp. 1355-1362(8)
Authors: Schiapparelli; Enguita-Germán; Balbuena; Rey; Lázcoz; Castresana

microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2
pp. 1363-1369(7)
Authors: Zhang, Hao; Cai, Xiaobing; Wang, Yang; Tang, Hao; Tong, Daki; Ji, Fang

A subset of microRNAs potentially acts as a convergent hub for upstream transcription factors in cancer cells
pp. 1371-1381(11)
Authors: Ohdaira; Sasaki; Yoshida

The impact of conventional or hypofractionated radiotherapy on voice quality and oncological outcome in patients with early glottic cancer
pp. 1383-1388(6)
Authors: Di Nicola, L.; Gravina, G. L.; Marampon, F.; Bonfili, P.; Buonopane, S.; Di Staso, M.; Festuccia, C.; Franzese, P.; Tombolini, M.; Tombolini, V.

Cooperation of actin-sequestering protein, thymosin β-4 and hypoxia inducible factor-1α in tumor cell migration
pp. 1389-1394(6)
Authors: Ryu; Im; Moon

The antiandrogen bicalutamide activates the androgen receptor (AR) with a mutation in codon 741 through the mitogen activated protein kinase (MARK) pathway in human prostate cancer PC3 cells
pp. 1395-1399(5)
Authors: Terakawa, Tomoaki; Miyake, Hideaki; Kumano, Masafumi; Sakai, Iori; Fujisawa, Masato

Suppressed protein expression of the death-associated protein kinase enhances 5-fluorouracil-sensitivity but not etoposide-sensitivity in human endometrial adenocarcinoma cells
pp. 1401-1405(5)
Authors: Tanaka, Tetsuji; Bai, Tao; Yukawa, Kazunori